Drug Profile
Research programme: biodefence vaccines - Vaxart
Alternative Names: Biodefense vaccines - Vaxart; Ebola virus vaccine - Vaxart; Marburg virus vaccine - Vaxart; Venezuelan equine encephalitis virus vaccine - VaxartLatest Information Update: 28 Mar 2023
Price :
$50
*
At a glance
- Originator Vaxart
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ebola virus infections; Marburg virus disease; Venezuelan equine encephalomyelitis
Most Recent Events
- 28 Mar 2023 Discontinued - Preclinical for Ebola virus infections (Prevention) in USA (PO)
- 28 Mar 2023 Discontinued - Preclinical for Marburg virus disease (Prevention) in USA (PO)
- 28 Mar 2023 Discontinued - Preclinical for Venezuelan equine encephalomyelitis (Prevention) in USA (PO)